Veloxis PK - A Phase 2, Double-Blind, Double-Dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-Daily for the Prevention of Acute Allograft Rejection in De Novo A

Grants and Contracts Details

StatusFinished
Effective start/end date12/3/126/30/14

Funding

  • ICON Clinical Research: $69,091.00